| Delayed Deutsche Boerse AG Other stock markets | 5-day change | 1st Jan Change | ||
| 10.50 EUR | +1.94% |  | +3.96% | -13.22% |
| Jul. 11 | Piper Sandler Adjusts Price Target on Sally Beauty to $13 From $14, Maintains Overweight Rating | MT |
| Jul. 01 | Sally Beauty Holdings, Inc.(NYSE:SBH) dropped from Russell 2000 Growth-Defensive Index | CI |
Published financial data: SALLY BEAUTY HOLDINGS, INC.
Annual
Annual
Quarterly
Halfyear
YTD
LTM
| Fiscal Period: September | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 13.64 | 6.88 | 9.24 | 8.84 | 7.98 | |||||
Return on Total Capital | 18.82 | 8.82 | 11.57 | 11.28 | 10.05 | |||||
Return On Equity % | -165.18 | -504.66 | 161.97 | 63.91 | 46.01 | |||||
Return on Common Equity | -165.18 | -504.66 | 161.97 | 63.91 | 46.01 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.29 | 48.82 | 50.44 | 50.78 | 50.76 | |||||
SG&A Margin | 34.7 | 37.96 | 37.09 | 40.73 | 41.58 | |||||
EBITDA Margin % | 14.59 | 10.85 | 13.59 | 12.67 | 11.83 | |||||
EBITA Margin % | 12.1 | 8.07 | 11.12 | 10.16 | 9.17 | |||||
EBIT Margin % | 11.81 | 7.82 | 10.95 | 10.05 | 9.08 | |||||
Income From Continuing Operations Margin % | 7.01 | 3.22 | 6.19 | 4.81 | 4.95 | |||||
Net Income Margin % | 7.01 | 3.22 | 6.19 | 4.81 | 4.95 | |||||
Net Avail. For Common Margin % | 7.01 | 3.22 | 6.19 | 4.81 | 4.95 | |||||
Normalized Net Income Margin | 5.83 | 3.13 | 5.34 | 4.75 | 4.42 | |||||
Levered Free Cash Flow Margin | 5.03 | 6.98 | 7.38 | 1.29 | 3.65 | |||||
Unlevered Free Cash Flow Margin | 6.48 | 8.62 | 8.78 | 2.73 | 4.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.85 | 1.41 | 1.35 | 1.41 | 1.41 | |||||
Fixed Assets Turnover | 12.35 | 6.06 | 4.6 | 4.56 | 4.39 | |||||
Receivables Turnover (Average Receivables) | 84.68 | 89.28 | 113.61 | 114.37 | 110.43 | |||||
Inventory Turnover (Average Inventory) | 2.07 | 2.04 | 2.28 | 2.08 | 1.92 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.55 | 2.54 | 2.08 | 1.7 | 2.12 | |||||
Quick Ratio | 0.39 | 1.01 | 0.7 | 0.21 | 0.34 | |||||
Operating Cash Flow to Current Liabilities | 0.7 | 0.76 | 0.57 | 0.23 | 0.43 | |||||
Days Sales Outstanding (Average Receivables) | 4.31 | 4.1 | 3.21 | 3.19 | 3.31 | |||||
Days Outstanding Inventory (Average Inventory) | 176.13 | 179.81 | 160.22 | 175.66 | 190.04 | |||||
Average Days Payable Outstanding | 53.79 | 56.76 | 48.73 | 53.29 | 52.05 | |||||
Cash Conversion Cycle (Average Days) | 126.65 | 127.15 | 114.7 | 125.57 | 141.3 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -2.64K | 15.18K | 692.13 | 590.59 | 329.34 | |||||
Total Debt / Total Capital | 103.93 | 99.35 | 87.38 | 85.52 | 76.71 | |||||
LT Debt/Equity | -2.64K | 14.19K | 636.41 | 513.49 | 298.95 | |||||
Long-Term Debt / Total Capital | 103.93 | 92.84 | 80.34 | 74.36 | 69.63 | |||||
Total Liabilities / Total Assets | 102.87 | 99.47 | 90.14 | 88.6 | 81.33 | |||||
EBIT / Interest Expense | 4.75 | 2.78 | 4.54 | 4.1 | 4.64 | |||||
EBITDA / Interest Expense | 5.87 | 6.27 | 8.28 | 7.85 | 9.34 | |||||
(EBITDA - Capex) / Interest Expense | 4.75 | 5.14 | 7.49 | 6.78 | 8.1 | |||||
Total Debt / EBITDA | 2.82 | 3.79 | 2.51 | 2.36 | 2.46 | |||||
Net Debt / EBITDA | 2.69 | 2.96 | 1.99 | 2.27 | 2.28 | |||||
Total Debt / (EBITDA - Capex) | 3.48 | 4.61 | 2.78 | 2.73 | 2.84 | |||||
Net Debt / (EBITDA - Capex) | 3.33 | 3.6 | 2.2 | 2.62 | 2.63 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.43 | -9.34 | 10.26 | -1.53 | -2.29 | |||||
Gross Profit, 1 Yr. Growth % | -1.74 | -10.2 | 13.94 | -0.88 | -2.33 | |||||
EBITDA, 1 Yr. Growth % | -0.77 | -32.54 | 42.43 | -7.77 | -10.55 | |||||
EBITA, 1 Yr. Growth % | -0.76 | -39.52 | 58.48 | -10.08 | -13.89 | |||||
EBIT, 1 Yr. Growth % | -0.7 | -40 | 61.4 | -9.65 | -13.86 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.26 | -58.31 | 111.8 | -23.47 | 0.57 | |||||
Net Income, 1 Yr. Growth % | 5.26 | -58.31 | 111.8 | -23.47 | 0.57 | |||||
Normalized Net Income, 1 Yr. Growth % | -0.81 | -51.34 | 101.56 | -12.39 | -9.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 8.65 | -56.19 | 112.12 | -20.95 | 1.81 | |||||
Accounts Receivable, 1 Yr. Growth % | -10.91 | -17.49 | -8.34 | 4.53 | -2 | |||||
Inventory, 1 Yr. Growth % | 0.91 | -14.52 | 6.98 | 7.46 | 4.15 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.66 | 163.01 | 0.52 | -1.77 | 4.62 | |||||
Total Assets, 1 Yr. Growth % | 0.05 | 37.97 | -1.66 | -9.49 | 5.76 | |||||
Tangible Book Value, 1 Yr. Growth % | -25.54 | -10.76 | -45.79 | -10.52 | -71.88 | |||||
Common Equity, 1 Yr. Growth % | -77.54 | -125.6 | 1.72K | 4.59 | 73.26 | |||||
Cash From Operations, 1 Yr. Growth % | -14.02 | 33.23 | -10.55 | -59.02 | 59.3 | |||||
Capital Expenditures, 1 Yr. Growth % | 24.56 | 2.88 | -33.33 | 34.3 | -8.57 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -28.63 | 25.86 | 20.1 | -82.69 | 147.36 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -23.99 | 20.54 | 15.03 | -69.15 | 62.57 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.79 | -5.47 | -0.02 | 4.2 | -1.91 | |||||
Gross Profit, 2 Yr. CAGR % | -1.39 | -6.07 | 1.15 | 6.27 | -1.61 | |||||
EBITDA, 2 Yr. CAGR % | -4.22 | -18.12 | -3.49 | 12.86 | -8.75 | |||||
EBITA, 2 Yr. CAGR % | -4.76 | -22.47 | -4.14 | 17.29 | -11.23 | |||||
EBIT, 2 Yr. CAGR % | -4.7 | -22.74 | -3.71 | 18.57 | -11 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 12.38 | -33.75 | -6.03 | 27.31 | -12.27 | |||||
Net Income, 2 Yr. CAGR % | 12.38 | -33.75 | -6.03 | 27.31 | -12.27 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.94 | -30.3 | -4.32 | 29.1 | -10.78 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 20.36 | -31.01 | -3.6 | 29.49 | -10.29 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.18 | -14.26 | -13.04 | -2.11 | 1.22 | |||||
Inventory, 2 Yr. CAGR % | 1.18 | -7.13 | -4.38 | 7.22 | 5.79 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.94 | 65.11 | 62.6 | -0.63 | 1.37 | |||||
Total Assets, 2 Yr. CAGR % | -0.01 | 17.49 | 16.48 | -5.66 | -2.16 | |||||
Tangible Book Value, 2 Yr. CAGR % | -18.43 | -18.48 | -30.44 | -30.35 | -49.84 | |||||
Common Equity, 2 Yr. CAGR % | -59.27 | -76.02 | 115.73 | 336.05 | 34.62 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.39 | 7.03 | 9.17 | -39.45 | -19.2 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.62 | 13.2 | -17.18 | -5.38 | 10.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -14.21 | -5.14 | 21.1 | -55.17 | -31.21 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -14.6 | -4.21 | 16.33 | -41.25 | -27.63 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.65 | -3.73 | -0.49 | -0.53 | 1.99 | |||||
Gross Profit, 3 Yr. CAGR % | -0.91 | -4.42 | 0.18 | 0.47 | 3.32 | |||||
EBITDA, 3 Yr. CAGR % | -1.97 | -14.78 | -2.55 | -5.09 | 5.13 | |||||
EBITA, 3 Yr. CAGR % | -3 | -18.14 | -2.97 | -6.16 | 6.67 | |||||
EBIT, 3 Yr. CAGR % | -2.94 | -18.32 | -2.66 | -5.73 | 7.48 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.8 | -19.25 | -2.41 | -12.25 | 17.69 | |||||
Net Income, 3 Yr. CAGR % | 6.8 | -19.25 | -2.41 | -12.25 | 17.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.57 | -21.84 | -2.95 | -7.08 | 14.83 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.64 | -14.06 | 0.32 | -9.77 | 19.51 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.78 | -8.84 | -12.33 | -7.53 | -2.07 | |||||
Inventory, 3 Yr. CAGR % | 1.65 | -4.35 | -2.65 | -0.58 | 6.19 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.01 | 38.9 | 39.94 | 37.45 | 1.09 | |||||
Total Assets, 3 Yr. CAGR % | -0.53 | 11.31 | 10.72 | 7.09 | -2 | |||||
Tangible Book Value, 3 Yr. CAGR % | -10.2 | -15.95 | -28.85 | -24.35 | -48.52 | |||||
Common Equity, 3 Yr. CAGR % | -39.78 | -65.11 | 1.49 | 69.48 | 220.57 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.28 | 7.54 | 0.82 | -21.25 | -16.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | -10.68 | 7.33 | -5.11 | -2.7 | -6.46 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.39 | -2.52 | 1.59 | -36.86 | -17.68 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 2.74 | -4.21 | 0.99 | -25.44 | -15.96 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.65 | -1.73 | -0.4 | -0.63 | -1.06 | |||||
Gross Profit, 5 Yr. CAGR % | 0.54 | -2.01 | -0.09 | -0.28 | -0.54 | |||||
EBITDA, 5 Yr. CAGR % | -0.85 | -8.33 | -2.58 | -4.74 | -4.97 | |||||
EBITA, 5 Yr. CAGR % | -2.23 | -11.22 | -3.46 | -5.6 | -6.23 | |||||
EBIT, 5 Yr. CAGR % | -2.16 | -11.29 | -3.25 | -5.32 | -5.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2 | -13.59 | 1.47 | -3.12 | -6.48 | |||||
Net Income, 5 Yr. CAGR % | 2 | -13.59 | 1.47 | -3.12 | -6.48 | |||||
Normalized Net Income, 5 Yr. CAGR % | -1.72 | -14.42 | -1.41 | -4.67 | -6.16 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.4 | -7.85 | 6.96 | 1.25 | -4.07 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.59 | -6.04 | -7.02 | -6.21 | -7.15 | |||||
Inventory, 5 Yr. CAGR % | 2.84 | -1.65 | -0.81 | 0.12 | 0.65 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.07 | 25.42 | 21.47 | 21.48 | 23.01 | |||||
Total Assets, 5 Yr. CAGR % | 0.92 | 6.69 | 5.96 | 4.19 | 5.38 | |||||
Tangible Book Value, 5 Yr. CAGR % | -8.13 | -8.74 | -18.92 | -22.04 | -38.13 | |||||
Common Equity, 5 Yr. CAGR % | -29.53 | -44.67 | 0.33 | -4.19 | 13.63 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.28 | 7.25 | 1.52 | -14.54 | -7.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7 | 0.8 | -13.34 | 2.05 | 0.96 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.4 | 2.04 | 14.56 | -28.63 | -12.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -4.3 | 0.81 | 7.97 | -21.28 | -11.51 |
- Stock Market
- Equities
- SBH Stock
- S7V Stock
- Financials Sally Beauty Holdings, Inc.
- Financial Ratios
